Artiva Biotherapeutics

1 follower


Artiva Biotherapeutics is advancing NK cell therapy and CAR-NK therapy for cancer, including blood cancers and solid tumors.

Employees

11-50

Links

Org chart

Fred Aslan
President & CEO

Fred Aslan

Collapse
Christopher Horan
Chief Technical Operations Officer
Peter Flynn
Cofounder & Strategic Advisor
Thorsten Graef
Chief Medical Officer
Jennifer Bush
Chief Operating Officer
Heather Raymon
Senior Vice President, Research And Early Development
Eugene Helsel
Regulatory Affairs Consultant
Sungyong Won
Vice President
Luis Solchaga
Head Of Manufacturing Sciences
Mark Bravo
Director of Information Technology (Head of IT)
Scott C.
Director, Quality Assurance